My Biotech Portfolio

My Portfolios

Legacy Merrill Portfolio
New Robindhood Portfolio

Last Updated 3/2/2023

Merrill Portfolio

TechBio
Company	Position	Cost Basis
RLAY	4.53%	$27.25
RXRX	4.53%	$15.05
EXAI	4.68%	$15.46
SDGR	4.68%	$43.83
Total	18.41%

CRISPR
Company	Position	Cost Basis
BEAM	5.24%	$9.20
NTLA	4.53%	$77.50
CRSP	0%	$0
VERV	0%	$0
Total	9.77%

SynBio
Company	Position	Cost Basis
DNA	5.41%	$6.37
TWST	5.41%	$68.30
Total	10.81%

Sequencing
Company	Position	Cost Basis
NVTA	4.53%	$12.25
PACB	4.38%	$17.79
Total	8.91%

iPSC
Company	Position	Cost Basis
IPSC	4.24%	$14.62
SANA	5.41%	$10.26
FATE	5.55%	$0.00
CRBU	3.95%	$17.12
Total	19.14%

Targeted Therapies
Company	Position	Cost Basis
BPMC	5.26%	$45.05
MRTX	4.53%	$42.43
KYMR	5.26%	$43.87
RVMD	3.79%	$29.98
GLUE	3.80%	$23.87
Total	22.65%

Dog Pound
Company	Position	Cost Basis
ARVN	3.65%	$73.92
CCCC	2.92%	$42.55
ERAS	3.65%	$17.24
Total	10.23%

Totals
Cash	Stock
.07%	99.93%

Last Updated 3/9/2023

Robinhood Portfolio

TechBio
Company	Position	Cost Basis
RLAY	5%	$16.35
RXRX	5%	$8.12
EXAI	5%	$6.59
ABCL	5%	$8.13
SDGR	5%	$25.04
Total	25%

CRISPR
Company	Position	Cost Basis
BEAM	5%	$37.35
NTLA	5%	$39.99
CRSP	5%	$48.83
VERV	5%	$18.31
PRME	5%	$15.42
Total	25%

Cell Engineering
Company	Position	Cost Basis
DNA	5%	$1.35
IPSC	5%	$4.68
SANA	5%	$3.56
FATE	5%	$5.75
CRBU	5%	$5.62
Total	25%

Personalized Medicine
Company	Position	Cost Basis
NVTA	5%	$1.68
BPMC	5%	$43.85
KYMR	5%	$32.43
RVMD	5%	$24.27
GLUE	5%	$6.05
Total	25%

Totals
Cash	Stock
0%	100%

* I am not a Financial Advisor. This is just My Strategy. Please refer to your financial advisor before making any investing decisions.